Combination of biomarkers for the prognosis of response or non-response to an anti-HCV treatment
US9879320B2 · kind B2 · utility
0Cited by
1References
26Claims
0Family size
Inventors
Key dates
| Filing date | Feb 9, 2012 |
| Grant date | Jan 30, 2018 |
| Priority date | — |
| Expiry date | Feb 9, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The application concerns means for predicting whether a subject infected with one or more HCVs has a high probability of responding to an anti-HCV treatment which will comprise the administration of interferon and of ribavirin or whether, in contrast, that subject has a high probability of not responding to that anti-HCV treatment. The means of the invention in particular involve assaying the levels of expression of selected genes, said selected genes being:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.